Price-sensitive press releases
2025-04-22
Shareholders in Moberg Pharma AB (publ), reg. no. 556697-7426, (the “Company”) are hereby convened to the Annual General Meeting on 22 May 2025 at 16:30 at Advokatfirman Schjødt, Hamngatan 27 in Stockholm.
2025-04-11
Moberg Pharma´s Annual report for 2024 has been published and is available on www.mobergpharma.com (https://www.mobergpharma.com/investors/annual-reports)
2025-02-11
TERCLARA CONTINUES TO LEAD THE MARKET AND EXPANDS TO NORWAY